Efficacy and safety of BRAF inhibition alone versus combined BRAF and MEK inhibition in melanoma: a meta-analysis of randomized controlled trials

Recent clinical studies have shown that combination therapy of BRAF and MEK inhibition provides more survival benefit than BRAF inhibition monotherapy. However, the adverse events due to BRAF and MEK inhibitors impact the physical comfort and social life of patients. Thus, in this study we have unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Mengdong, Yang, Xuekang, Liu, Jiaqi, Zhao, Bin, Cai, Weixia, Li, Yan, Hu, Dahai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458282/
https://www.ncbi.nlm.nih.gov/pubmed/28416755
http://dx.doi.org/10.18632/oncotarget.15632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458282/
https://www.ncbi.nlm.nih.gov/pubmed/28416755
http://dx.doi.org/10.18632/oncotarget.15632

Ejemplares similares